Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2003
12/03/2003CN1129599C Substituted benzothiazine/oxazine-2-amide derivatives, their prepn and application
12/03/2003CN1129597C Heterocyclic compounds and antitumor agent containing same as active ingredient
12/03/2003CN1129592C Method for preparation of citalopram
12/03/2003CN1129583C Compound as intermediates for use in preparation of optically active 2-imidazoline-5-one or 2-imidazoline-5-thionone derivatives
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/02/2003US6656964 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/02/2003US6656961 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
12/02/2003US6656957 Pyridine derivatives
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656946 For treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds
12/02/2003US6656934 2-amino-benzoxazinone derivatives for the treatment of obesity
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656911 Serine protease inhibitors
12/02/2003US6656910 Substituted oxadiazole, thiadiazoles and triazole peptoids for treating adult respiratory distress syndrome, septic shock, and myocardial ischemia-reperfusion injury
12/02/2003CA2193705C Merocyanine dye protein stains
11/2003
11/27/2003WO2003097640A1 Oxazolidinone derivatives as antibacterial agents
11/27/2003WO2003097639A1 Benzoxazine and benzoxazinone substituted triazoles
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097617A1 Cysteine protease inhibitors
11/27/2003WO2003097616A1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
11/27/2003WO2003097610A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/27/2003WO2003097609A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003WO2003097605A1 Pesticidal pyridinecarboxamide derivatives
11/27/2003WO2003097604A1 Pyridine carboxamide derivatives and their use as pesticides
11/27/2003WO2003097593A2 Protease inhibitors
11/27/2003WO2003097059A1 Polymorphic forms of phenyl oxazolidinone derivatives
11/27/2003WO2003097053A1 Compounds, compositions, and methods
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003097044A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003WO2003096984A2 Drug therapy for celiac sprue
11/27/2003WO2003096979A2 Drug therapy for celiac sprue
11/27/2003WO2003024899A3 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003US20030220505 Process and novel intermediates for preparing isoxazolin-3-ylacyl benzenes
11/27/2003US20030220495 Inhibitors of farnesyl protein transferase
11/27/2003US20030220494 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/27/2003US20030220381 Administering to a mammal 8-(5-Methyl-2-phenyl-oxazol-4-yl)-2-(1,2,3)triazoles, or 8-(5-methyl-2-phenyl-oxazol-4-yl)-2-pyrrol-1-yl- derivative for treating, obesity, hyperglycemia, diabetes etc
11/27/2003US20030220375 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
11/27/2003US20030220368 Superior Na+ channel inhibition activity; antiarrhythmic agents
11/27/2003US20030220359 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
11/27/2003US20030220338 Fungal efflux pump inhibitors
11/27/2003US20030220330 Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220317 Trypsin-like serine protease inhibitors; anticoagulants; side effect reduction
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003CA2487247A1 Drug therapy for celiac sprue
11/27/2003CA2486097A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003CA2484324A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003CA2484011A1 Cysteine protease inhibitors
11/27/2003CA2483600A1 Polymorphic forms of phenyl oxazolidinone derivatives
11/26/2003EP1364946A1 Isoxazoline derivative and herbicide comprising the same as active ingredient
11/26/2003EP1363906A2 Heterocyclic inhibitors of erk2 and uses thereof
11/26/2003EP1363902A1 Chemical compounds
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363889A1 Novel diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
11/26/2003EP1363887A1 Substituted quinolinecarboxamides as antiviral agents
11/26/2003EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363638A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/26/2003EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
11/26/2003EP1363632A1 Receptor selective cannabimimetic aminoalkylindoles
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP0828487B1 Agents for use against parasitic protozoa
11/26/2003EP0757038B1 Benzamide compound and medicinal use thereof
11/26/2003EP0689436B1 Taxanes not having an oxo group at c-9 and pharmaceutical compositions containing same
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458928A N-substituted benzothiophenesulfonamide derivatives
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/26/2003CN1128617C Preparation method for medicinal composition containing triazolyl derivative
11/25/2003US6653346 Amtiischemic and antiinflammatory agents
11/25/2003US6653334 Benzoxazole compound and pharmaceutical composition containing the same
11/25/2003US6653330 Amide-type triazole compounds
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653323 Aryl aniline β2 adrenergic receptor agonists
11/25/2003US6653314 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
11/25/2003US6653309 Binding ligands
11/25/2003US6653308 Anticancer agents; antidiabetic agents; antiinflammatory agents
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653305 For therapy of tumoral diseases, diseases of the lungs and respiratory tract
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6653302 Quinoline and quinazoline compounds useful in therapy
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653086 Fusion protein; ligand has not been identified; screening for agonists/ antagonists
11/20/2003WO2003095450A1 Isoxazole compounds and insecticide/acaricide
11/20/2003WO2003095448A1 Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
11/20/2003WO2003095445A1 New organic compounds for electroluminescence and organic electroluminescent devices using the same
11/20/2003WO2003095441A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/20/2003WO2003095434A1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003WO2003095430A1 Substituted pyrazolyl compounds for the treatment of inflammation
11/20/2003WO2003095426A1 Novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003053352A3 Therapeutic compounds for treating dyslipidemic conditions
11/20/2003WO2003029210A3 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
1 ... 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 ... 647